Evidence map›Paper›PMID 17967719›Full record

ReviewAutoimmunity reviews2007

Role of leukotriene B4 receptors in rheumatoid arthritis.

Steven Mathis, Venkatakrishna R Jala, Bodduluri Haribabu

Open access · greenAbstract readReview
In one paragraph

Review in Autoimmunity reviews, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Neutrophils: Beneficial and Harmful Cells in Septic Arthritis.International journal of molecular sciences · 2018
    Review
  6. Too much of a good thing: How modulating LTBSeminars in immunology · 2017
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Steven MathisTumor Immunobiology Program, James Graham Brown Cancer Center, University of Louisville Health Sciences, Louisville, KY 40202, United States; Departments of Microbiology and Immunology, University of Louisville Health Sciences, Louisville, KY 40202, United States.
Venkatakrishna R JalaTumor Immunobiology Program, James Graham Brown Cancer Center, University of Louisville Health Sciences, Louisville, KY 40202, United States; Departments of Microbiology and Immunology, University of Louisville Health Sciences, Louisville, KY 40202, United States.
Bodduluri HaribabuTumor Immunobiology Program, James Graham Brown Cancer Center, University of Louisville Health Sciences, Louisville, KY 40202, United States; Departments of Microbiology and Immunology, University of Louisville Health Sciences, Louisville, KY 40202, United States. Electronic address: H0bodd01@gwise.louisville.edu.
University of Louisville · US

Funding

Leukotriene B4 Receptors in Rheumatoid ArthritisR01AI052381 · NIAID · UNIVERSITY OF LOUISVILLE · PI BODDULURI, HARIBABU · 2003 to 2006
$1.1M
NIAID NIH HHS AI52381NIAID NIH HHS R01 AI052381
6 · The paper itself

Abstract

The purpose of this review is to summarize the role that murine models of arthritis are playing in the understanding of human rheumatoid arthritis and how leukotriene B(4) (LTB(4)) is emerging as an important target in this field. Both the collagen-induced arthritis (CIA) model and the K/BxN serum transfer arthritis model have contributed to outline the potential mechanisms involved in inflammatory arthritis. Indeed, the CIA model has contributed to the development of effective anti-TNFalpha and anti-IL-1beta based treatments for RA that are currently in the clinic. Many recent studies in mouse models have suggested a critical role for LTB(4) and its receptors in the development of inflammatory arthritis. Inhibitors of LTB(4) biosynthesis as well as LTB(4) receptors are protective in mouse models of RA and mice deficient in the LTB(4) biosynthetic enzymes or LTB(4) receptors are resistant to disease development suggesting several promising targets for RA in this pathway.

Indexed as

AnimalsArthritis, ExperimentalArthritis, RheumatoidCytokinesDisease Models, AnimalLeukotriene B4Receptors, Leukotriene B4CytokinesLeukotriene B4Receptors, Leukotriene B4

Identifiers

PMID17967719
PMCPMC2349985
OpenAlexW2016157104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.